Farber disease: Clinical presentation, pathogenesis and a new approach to treatment

Pediatric Rheumatology

Volumn 5, Issue , 2007, Pages

  Ehlert, Karoline ^a   Frosch, Michael ^a   Fehse, Natalja ^b   Zander, Axel ^b   Roth, Johannes ^a   Vormoor, Josef ^a,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; STEROID; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY; VANCOMYCIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; ENTERITIS; FARBER DISEASE; GRAFT VERSUS HOST REACTION; GRANULOMA; HISTOCOMPATIBILITY; HISTOPATHOLOGY; HUMAN; INTRACRANIAL PRESSURE; JOINT CONTRACTURE; JOINT MOBILITY; JOINT SURGERY; MYELOABLATIVE CONDITIONING; NEUROTOXICITY; PATHOGENESIS; PHENOTYPE; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 37549022394     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-5-15     Document Type: Review

References (27)

1. Farber S A lipid metabolic Aisorder: Disseminated lipogranulomatosis: a syndrome with similarity to, and important difference from, Niemann-Pick and Hand-Schüller-Christian disease American Journal of Diseases in Childhood 1952, 84(4):499-500.
2. Farber S Cohen J Uzman LL Lipogranulomatosis: A new lipo-glycoprotein storage disease Journal of Mt Sinai Hospital N Y 1957, 24(6):816-837.
3. Levade T Moser HW Fensom AH Harzer K Moser AB Salavayre R Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells Journal of Neurological Sciences 1995, 134(1-2):108-114. 10.1016/0022-510X(95)00231-0
4. Moser HW Linke T Fensom AH Levade T Sandhoff K Acid ceramidase deficiency: Farber lipogranulomatosis The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill Scriver CR 8 2001:3573-3585.
5. Pavone L Moser HW Mollica F Reitano C Durand P Farber's lipogranulomatosis: Ceramidase deficiency and prolonged survival in three relatives Johns Hopkins Medical Journal 1980, 147:193-196. 7441940
6. Antonarakis SE Valle D Moser HW Kishimoto Y Phenotypic variability in siblings with Farber disease Journal of Pediatrics 1984, 104:406-409. 6423791
7. Eviatar L Sklower SL Wisniewski K Feldman RS Gochoco A Farber (lipogranulomatosis): An unusual presentation in a black child Pediatric Neurology 1986, 2:371-374. 10.1016/0887-8994(86)90082-2 2854742
8. Fusch C Huenges R Moser HW Sewell AC Roggendorf W Kusterman K Harzer K A case combined Farber's and Sandhoff's disease European Journal of Pediatrics 1989, 148:558-562. 10.1007/BF00441558 2744019
9. Schnabel D Schröder M Furst W Klein A Hurwitz R Zenk T Weber J Harzer K Paton BC Poulos A Suzuki K Sandhoff K Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene Journal of Biochemical Chemistry 1992, 267(5):3312-3315.
10. Hoang TR Hammermuller A Mix E Kreutzer HJ Goerlich R Kohler H Nizze H Thiesen HJ Ibrahim SM A proinflammatory role for Fas in joints of mice with collagen-induced arthritis Arthritis Research and Therapy 2004, 6(5):R404-414. 10.1186/ar1205
11. Ma Y Liu H Tu-Rapp H Thiesen HJ Ibrahim SM Cole SM Pope RM Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signalling and promotes chronic inflammation Nature Immunology 2004, 5(4):380-387. 10.1038/ni1054 15004557
12. Grassme H Jekle A Riehle A Schwarz H Berger J Sandhoff K Kolesnick R Gulbins E CD95 signalling via ceramide-rich membrane rafts Journal of Biological Chemistry 2001, 276(23):20589-20596. 10.1074/jbc.M101207200 11279185
13. Cremesti A Paris F Grassme H Holler N Tschopp J Fuks Z Gulbins E Kolesnick R Ceramide enables fas to cap and kill Journal of Biological Chemistry 2001, 276(26):23954-23961. 10.1074/jbc.M101866200 11287428
14. Levade T Jaffrezou JP Signalling sphingomyelinases: Which, where, how and why? Biochemical and Biophysical Acta 1999, 1438(1):1-17.
15. Burek C Roth J Koch HG Harzer K Los M Schulze-Osthoff K The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells Oncogene 2001, 20(45):6493-6502. 10.1038/sj.onc.1204841 11641773
16. Mathias S Pena LA Kolesnick RN Signal transduction of stress via ceramide Biochemical Journal 1998, 335:465-480. 1219804 9794783
17. Sanders JE Bone marrow transplantation for pediatric malignancies Pediatric clinics of North America 1997, 44(4):1005-1020. 10.1016/ S0031-3955(05)70542-3 9286297
18. Vormoor J Marquardt T Hematopoietic cell transplantation in inborn errors of metabolism Current opinion in organ transplantation 2004, 9:43-48. 10.1097/00075200-200403000-00010
19. Malatack JJ Consolini DM Bayever E The status of hematopoietic stem cell transplantation in lysosomal storage disease Pediatric Neurology 2003, 29(5):391-403. 10.1016/j.pediatrneurol.2003.09.003 14684234
20. Wilcox WR Lysosomal storage disorders: The need for better pediatric recognition and comprehensive care The Journal of Pediatrics 2004, 144:S3-S14. 10.1016/j.jpeds.2004.01.049 15126978
21. Schiffmann R Brady RO New prospects for the treatment of lysosomal storage diseases Drugs 2002, 62(5):733-742. 10.2165/ 00003495-200262050-00002 11929328
22. Peters C Steward CG Hematopoietic cell transplantation for inherited metabolic diseases: An overview of outcomes and practice guidelines Bone marrow transplantation 2003, 31:229-239. 10.1038/sj.bmt.1703839 12621457
23. Baumann M Korenke GC Weddige-Diedrichs A Wilichowski E Hunneman DH Wilken B Brockmann K Klingebiel T Niethammer D Kuehl J Ebell W Hanefeld F Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy European Journal of Pediatrics 2003, 162:6-14. 10.1007/s00431-002-1097-3 12486501
24. Buckley RH A historical review of bone marrow transplantation for immunodeficiencies Journal of allergy and clinical immunology 2004, 113(4):793-800. 10.1016/j.jaci.2004.01.764
25. Souillet G Guibaud P Fensom AH Maire I Zabot MT Outcome of displacement bone marrow transplantation in Farber's disease: A report of a case Correction of certain genetic diseases by transplantation London: COGENT Hobbs JR 1989:137-141.
26. Yeager AM Armfield-Uhas K Coles CD Davis PC Krause WL Moser HW Bone marrow transplantation for infantile ceramidase deficiency (Farber disease) Bone marrow transplantation 2000, 26:357-363. 10.1038/ sj.bmt.1702489 10967581
27. Vormoor J Ehlert K Groll AH Koch HG Frosch M Roth J Successful hematopoietic stem cell transplantation in Farber disease The Journal of Pediatrics 2004, 144(1):132-134. 10.1016/j.jpeds.2003.09.051 14722533